Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery

This publication has 18 references indexed in Scilit:

• Interleukin-6 Serum Level Correlates with Survival in Advanced Gastrointestinal Cancer Patients but Is Not an Independent Prognostic Indicator
  Journal of Interferon & Cytokine Research, 2001
• The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study: Figure 1
  Journal of Clinical Pathology, 2000
• The host—tumor immune conflict: from immunosuppression to resistance and destruction
  Immunology Today, 1997
• Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck
  Annals of Surgical Oncology, 1997
• Escape from Host-Antitumor Immunity
  Critical Reviews™ in Oncogenesis, 1997
• The role of cytokines in cancer
  Cytokine & Growth Factor Reviews, 1996
• Increased interleukin-10 serum levels in patients with solid tumours
  Cancer Letters, 1996
• Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer
  Cancer, 1994
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
  Journal of Clinical Investigation, 1989